Latest News about NVO
Recent news which mentions NVO
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger Growth Driver in the Long Run
June 02, 2024
Tickers
NVO
From Motley Fool
From Motley Fool
Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes
May 31, 2024
From Benzinga
From InvestorPlace
From Benzinga
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
May 30, 2024
From Benzinga
From Benzinga
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29, 2024
From Benzinga
A New Name in Weight Loss Drugs
May 28, 2024
From Motley Fool
Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System
May 28, 2024
From Benzinga
From InvestorPlace
Ozempic Maker Novo Nordisk's Increasing Influence On Denmark's Employment Raises Economic Concerns
May 28, 2024
From Benzinga
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
From Motley Fool
From InvestorPlace
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
May 27, 2024
From Benzinga
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
From InvestorPlace
From Benzinga
From Motley Fool
3 High-Flying Stocks That Could Soar Even More
May 25, 2024
From Motley Fool
From Benzinga
Novo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease Progression
May 24, 2024
From Benzinga
From InvestorPlace
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
May 23, 2024
From Benzinga
From InvestorPlace
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
May 22, 2024
From Benzinga
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
May 22, 2024
From Benzinga
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
May 22, 2024
From Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
